Accès ouvert
2026
article
OpenAlex
Clotilde Allavena, Sean P. Fleming, Colin Deschanvres, Philippe Mariot et autres
Doravirine (DOR)-based regimens are recommended as alternative options for virologically suppressed people with HIV (VS-PWH). However, data supporting their long-term use in real-world settings are scarce. This large study described the long-term effectiveness and safety of DOR-based regimens following treatment switch in …
fr, us, gp, mq
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Axel Ursenbach, François Séverac, Archia Chahard, Dulce Alfaiate et autres
Abstract Background People with HIV (PWH) are at higher risk of developing chronic hepatitis B, and therefore vaccination against HBV is highly recommended. Clearance of hepatitis B surface antibody (anti-HBs) over time is poorly described in PWH. Methods We retrospectively included vaccinated …
fr
(code pays fourni par la source)
2021
article
OpenAlex
Lise Cuzin, Clotilde Allavena, Laurent Cotte, Cyrille Delpierre et autres
OBJECTIVES: Even in an 'optimal' health system, patients' characteristics may have an impact on their care. We investigated whether age, gender and place of birth have an impact in the HIV care continuum in France, a country with a universal free healthcare …
fr, mq
(code pays fourni par la source)
2021
article
OpenAlex
Laurent Cotte, Laurent Hocqueloux, Maeva Lefebvre, Pierre François Pradat et autres
BACKGROUND: The arrival of highly effective, well-tolerated, direct-acting antiviral agents (DAA) led to a dramatic decrease in hepatitis C virus (HCV) prevalence. Human immunodeficiency virus (HIV)-HCV-coinfected patients are deemed a priority population for HCV elimination, while a rise in recently acquired HCV …
fr, mq
(code pays fourni par la source)
2017
article
OpenAlex
Pierre François Pradat, Pascal Puglièse, Isabelle Poizot‐Martin, Marc‐Antoine Valantin et autres
fr, gp, mq
(code pays fourni par la source)